$2.47 Billion is the total value of Woodford Investment Management Ltd's 8 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | Sell | ABBVIE INC | $695,649,000 | -3.6% | 11,029,800 | -5.4% | 28.12% | -17.1% |
| PRTA | Sell | PROTHENA CORP PLC | $617,384,000 | +71.4% | 10,301,751 | -0.0% | 24.96% | +47.5% |
| RAI | Sell | REYNOLDS AMERICAN INC | $358,732,000 | -28.6% | 7,608,324 | -18.4% | 14.50% | -38.6% |
| ALKS | Buy | ALKERMES PLC | $355,031,000 | +9.0% | 7,549,033 | +0.2% | 14.35% | -6.2% |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $340,915,000 | +72.0% | 9,407,137 | +7.7% | 13.78% | +48.0% |
| BIIB | Buy | BIOGEN INC | $53,350,000 | +1003.2% | 170,430 | +752.2% | 2.16% | +850.2% |
| GILD | New | GILEAD SCIENCES INC | $38,516,000 | – | 486,800 | +100.0% | 1.56% | – |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | $14,062,000 | -6.7% | 25,915,937 | 0.0% | 0.57% | -19.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-05-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PROTHENA CORP PLC | 19 | Q2 2019 | 37.7% |
| ALKERMES PLC | 18 | Q1 2019 | 28.0% |
| THERAVANCE BIOPHARMA INC | 17 | Q3 2019 | 71.3% |
| BIOGEN INC | 12 | Q1 2019 | 9.8% |
| ABBVIE INC | 9 | Q3 2017 | 33.9% |
| NORTHWEST BIOTHERAPEUTICS INC | 9 | Q4 2016 | 12.7% |
| REYNOLDS AMERICAN INC | 7 | Q3 2016 | 45.9% |
| EVOFEM BIOSCIENCES INC | 7 | Q3 2019 | 20.3% |
| AUTOLUS THERAPEUTICS PLC | 6 | Q3 2019 | 33.9% |
| GILEAD SCIENCES INC | 6 | Q4 2017 | 7.6% |
View Woodford Investment Management Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evofem Biosciences, Inc.Sold out | February 04, 2020 | 0 | 0.0% |
| Nightstar Therapeutics plcSold out | February 04, 2020 | 0 | 0.0% |
| Theravance Biopharma, Inc. | November 08, 2019 | 429,770 | 0.8% |
| Autolus Therapeutics plc | October 09, 2019 | 2,095,127 | 4.7% |
| NuCana plc | September 09, 2019 | 1,538,000 | 4.8% |
| Prothena Corp plcSold out | September 09, 2019 | 0 | 0.0% |
| NORTHWEST BIOTHERAPEUTICS INC | February 14, 2019 | 24,815,028 | 4.8% |
View Woodford Investment Management Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-04 |
| SC 13G/A | 2020-02-04 |
| 13F-HR | 2020-01-27 |
| 13F-HR/A | 2019-11-12 |
| 13F-HR | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-10-09 |
| SC 13G/A | 2019-09-09 |
| SC 13G/A | 2019-09-09 |
View Woodford Investment Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.